Company: PIII
Filing Date: 2025-07-09
Form Type: 8-K
Source: 0001628280-25-034559
Chunk: 0

Company: P3 Health Partners Inc.
Filing Date: 2025-07-09
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 2, 2025, Dr. Sherif Abdou informed the Board of Directors (the “ Board”) of P3 Health Partners Inc. (the “ Company”) of his resignation from the Board effective as of the same date. Dr. Abdou’s previously announced transition services agreement with the Company expired on April 30, 2025 and such services have been concluded. On that same day the Nominating Committee of the Board provided the Board with its unanimous recommendation that Dr. Aric Coffman be appointed to fill the vacancy created by Dr. Abdou’s resignation.

On July 8, 2025, the Board unanimously approved the appointment of Dr. Coffman. Dr. Coffman will serve as a Class I director with a term expiring in 2028.

There are no arrangements or understandings between Dr. Coffman and the Company, or any other person, pursuant to which he was selected as a director. Dr. Coffman does not qualify as an independent director under applicable exchange listing standards because of Dr. Coffman’s employment as Chief Executive Officer of the Company, and as a result, Dr. Coffman is not expected to serve on any Board committees.

Dr. Coffman, as Chief Executive Officer of the Company, will not receive additional compensation for his service on the Board.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                        P3 Health Partners Inc.  
  Date:      July 9, 2025      By:      /s/ Aric Coffman, M. D.  
                                        Aric Coffman, M. D.      
                                        Chief Executive Officer